On Monday, Abivax ADR (NASDAQ: ABVX) was 6.77% up from the session before settling in for the closing price of $8.27. A 52-week range for ABVX has been $4.77 – $14.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -1.44% over the last five years. When this article was written, the company’s average yearly earnings per share was at 3.78%. With a float of $55.63 million, this company’s outstanding shares have now reached $63.35 million.
The firm has a total of 69 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -1168.96%, and the pretax margin is -1190.99%.
Abivax ADR (ABVX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Abivax ADR stocks. The insider ownership of Abivax ADR is 12.35%, while institutional ownership is 39.28%.
Abivax ADR (ABVX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.83% during the next five years compared to -1.44% drop over the previous five years of trading.
Abivax ADR (NASDAQ: ABVX) Trading Performance Indicators
You can see what Abivax ADR (ABVX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.02, a number that is poised to hit -0.93 in the next quarter and is forecasted to reach -2.39 in one year’s time.
Technical Analysis of Abivax ADR (ABVX)
Analysing the last 5-days average volume posted by the [Abivax ADR, ABVX], we can find that recorded value of 0.57 million was better than the volume posted last year of 0.22 million. As of the previous 9 days, the stock’s Stochastic %D was 83.05%.
During the past 100 days, Abivax ADR’s (ABVX) raw stochastic average was set at 97.84%, which indicates a significant increase from 96.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was lower than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.93, while its 200-day Moving Average is $7.65. Now, the first resistance to watch is $9.13. This is followed by the second major resistance level at $9.43. The third major resistance level sits at $9.94. If the price goes on to break the first support level at $8.32, it is likely to go to the next support level at $7.81. Should the price break the second support level, the third support level stands at $7.51.
Abivax ADR (NASDAQ: ABVX) Key Stats
There are 63,454K outstanding shares of the company, which has a market capitalization of 560.44 million. As of now, sales total 0 K while income totals -190,710 K. Its latest quarter income was 0 K while its last quarter net income were -55,170 K.
